|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Cns Pharmaceuticals, Inc. (CNSP) |
|
|
$0.17 0.00 (0.00%) as of 4:30 Mon 11/28
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
1,330,000 |
| Market
Cap: |
222.24(K) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.1671 - $0.1671 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CNS Pharmaceuticals is a clinical pharmaceutical company. Co. focuses on the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. Co.'s primary focus is on the development and testing of Berubicin, a development stage anthracycline intended to treat glioblastoma. Berubicin intercalates into deoxyribonucleic acid (DNA) and interrupts topoisomerase II activity, resulting in the inhibition of DNA replication and repair, and RNA and protein synthesis.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
299,998 |
329,748 |
357,521 |
| Total Buy Value |
$0 |
$90,000 |
$129,122 |
$159,009 |
| Total People Bought |
0 |
4 |
4 |
4 |
| Total Buy Transactions |
0 |
4 |
6 |
10 |
| Total Shares Sold |
0 |
0 |
0 |
94,298 |
| Total Sell Value |
$0 |
$0 |
$0 |
$133,114 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
17 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Evans Carl Anthony |
Director |
– • – |
2024-02-01 |
4 |
B |
$0.30 |
$10,000 |
D/D |
33,333 |
33,458 |
2.39 |
- |
|
| Downs Christopher |
Chief Financial Officer |
• – – |
2024-02-01 |
4 |
B |
$0.30 |
$20,000 |
D/D |
66,666 |
103,438 |
2.74 |
- |
|
| Climaco John M |
Chief Executive Officer |
• • – |
2024-02-01 |
4 |
B |
$0.30 |
$50,000 |
D/D |
166,666 |
215,676 |
2.81 |
- |
|
| Gumulka Jerzy |
Director |
– • – |
2024-02-01 |
4 |
B |
$0.30 |
$10,000 |
D/D |
33,333 |
43,006 |
2.39 |
- |
|
| Downs Christopher |
Chief Financial Officer |
• – – |
2023-08-22 |
4 |
B |
$1.27 |
$34,177 |
D/D |
27,000 |
36,772 |
2.74 |
- |
|
| Climaco John M |
Chief Executive Officer |
• • – |
2023-08-16 |
4 |
B |
$1.80 |
$4,945 |
D/D |
2,750 |
49,010 |
2.73 |
- |
|
| Climaco John M |
Chief Executive Officer |
• • – |
2023-04-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
46,260 |
|
- |
|
| Downs Christopher |
Chief Financial Officer |
• – – |
2023-04-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
521 |
9,772 |
|
- |
|
| Gumulka Jerzy |
Director |
– • – |
2023-04-19 |
4 |
B |
$1.70 |
$4,250 |
D/D |
2,500 |
9,673 |
2.31 |
- |
|
| Downs Christopher |
Chief Financial Officer |
• – – |
2023-04-17 |
4 |
B |
$3.20 |
$9,920 |
D/D |
3,100 |
9,251 |
2.74 |
- |
|
| Climaco John M |
Chief Executive Officer |
• • – |
2023-04-12 |
4 |
B |
$0.69 |
$10,409 |
D/D |
15,000 |
45,010 |
2.81 |
- |
|
| Gumulka Jerzy |
Director |
– • – |
2023-04-10 |
4 |
B |
$0.74 |
$5,308 |
D/D |
7,173 |
7,173 |
2.39 |
- |
|
| Priebe Waldemar |
|
• • • |
2023-03-28 |
4 |
S |
$1.04 |
$10,400 |
I/I |
(10,000) |
156,807 |
|
- |
|
| Priebe Waldemar |
|
• • • |
2023-03-27 |
4 |
S |
$1.09 |
$5,450 |
I/I |
(5,000) |
166,807 |
|
- |
|
| Priebe Waldemar |
|
• • • |
2023-03-24 |
4 |
S |
$1.08 |
$5,400 |
I/I |
(5,000) |
171,807 |
|
- |
|
| Priebe Waldemar |
|
• • • |
2023-03-23 |
4 |
S |
$1.08 |
$10,800 |
I/I |
(10,000) |
176,807 |
|
- |
|
| Priebe Waldemar |
|
• • • |
2023-03-22 |
4 |
S |
$1.08 |
$5,400 |
I/I |
(5,000) |
186,807 |
|
- |
|
| Priebe Waldemar |
|
• • • |
2023-03-21 |
4 |
S |
$1.10 |
$5,500 |
I/I |
(5,000) |
191,807 |
|
- |
|
| Priebe Waldemar |
|
• • • |
2023-03-20 |
4 |
S |
$1.08 |
$5,400 |
I/I |
(5,000) |
196,807 |
|
- |
|
| Priebe Waldemar |
|
• • • |
2023-03-17 |
4 |
S |
$1.13 |
$5,650 |
I/I |
(5,000) |
201,807 |
|
- |
|
| Priebe Waldemar |
|
• • • |
2023-03-16 |
4 |
S |
$1.24 |
$6,200 |
I/I |
(5,000) |
206,807 |
|
- |
|
| Priebe Waldemar |
|
• • • |
2023-03-15 |
4 |
S |
$1.22 |
$6,100 |
I/I |
(5,000) |
211,807 |
|
- |
|
| Priebe Waldemar |
|
• • • |
2023-03-14 |
4 |
S |
$1.35 |
$6,750 |
I/I |
(5,000) |
216,807 |
|
- |
|
| Priebe Waldemar |
|
• • • |
2023-03-13 |
4 |
S |
$1.30 |
$6,500 |
I/I |
(5,000) |
221,807 |
|
- |
|
| Priebe Waldemar |
|
• • • |
2023-03-10 |
4 |
S |
$1.29 |
$6,450 |
I/I |
(5,000) |
226,807 |
|
- |
|
39 Records found
|
|
Page 1 of 2 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
